Akcea Therapeutics, Inc.

Mar 26, 2018

Ionis and Akcea Present New Data from ATTR Amyloidosis Program at 16th International Symposium on Amyloidosis

Mar 15, 2018

Ionis and Akcea Partner to Commercialize Inotersen for hATTR

Jul 27, 2017

Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

Jul 19, 2017

Akcea Therapeutics Announces Closing of Initial Public Offering

Jul 13, 2017

Akcea Therapeutics Announces Pricing of Initial Public Offering